Why the study?
New percutaneous mechanical circulatory support devices have become commercially available with differing hemodynamic effects and clinical applicability requiring expert consensus guidance.
Population
Patients undergoing high-risk PCI, cardiogenic shock, acute decompensated heart failure, right-sided support, and pediatric populations
Comparison
Various percutaneous mechanical circulatory support devices including intra-aortic balloon pump, axial flow pumps, TandemHeart, and ECMO
Design
Clinical expert consensus statement and review
Authors
Loading...
Guides percutaneous MCS use in high-risk PCI, CS, and HF; extends physiologic rationale into standardized clinical and research frameworks.
This consensus statement provides comprehensive guidance on the selection and use of various percutaneous mechanical circulatory support devices in clinical practice.
Rihal et al. (2015) conducted a review in Cardiogenic shock, acute decompensated heart failure, high-risk percutaneous coronary intervention. Percutaneous mechanical circulatory support devices was evaluated. This clinical expert consensus statement reviews the physiologic impact, insertion, monitoring, and clinical applicability of percutaneous mechanical circulatory support devices in cardiovascular care.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: